Complete heart block: Determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy

被引:78
|
作者
Chang, SM [1 ]
Nagueh, SF [1 ]
Spencer, WH [1 ]
Lakkis, NM [1 ]
机构
[1] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA
关键词
D O I
10.1016/S0735-1097(03)00623-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The purpose of this paper is to examine the incidence and determinants of permanent complete heart block (CHB) after nonsurgical septal reduction therapy (NSRT), and to evaluate the clinical impact of permanent pacemaker (PPM) placement. BACKGROUND Nonsurgical septal reduction therapy with ethanol improves the clinical and hemodynamic parameters in patients with symptomatic hypertrophic obstructive cardiomyopathy. Complete heart block is a common complication after NSRT. METHODS The database of 261 consecutive patients who underwent NSRT at Baylor College of Medicine was reviewed. Clinical variables that were considered as possible determinants for CHB after NSRT were: age, gender, New York Heart Association (NYHA) functional class, left ventricular outflow tract (LVOT) gradient at rest or with provocation, septal thickness, and baseline exercise duration. For electrocardiographic (ECG) variables, the presence of first-degree atrioventricular (AV) block, bifascicular block, left bundle branch block, atrial fibrillation, and left ventricular hypertrophy were analyzed. In addition, the volume of ethanol injected, the method of administration of ethanol (i.e., bolus vs. slow injection [over 30 to 60 s]), number of septal arteries occluded, use of myocardial echocardiography, and infarct size as determined by peak creatine kinase level. RESULTS Of 261 consecutive patients, 37 had PPM or automatic implantable cardiac defibrillator placed before NSRT. Of the remaining 224 patients, 31 (14%) developed CHB after the procedure. Multivariate logistic regression analysis showed that female gender (odds ratio [OR] 4.3; p = 0.02), bolus injection of ethanol (OR 51; p = 0.004), injecting more than one septal artery (OR 4.6; p = 0.016), the presence of left bundle branch block (OR 39; p = 0.002), and first-degree AV block (OR 14; p = 0.001) on the baseline ECG are independent predictors of CHB after NSRT. Patients requiring PPM placement had a similar improvement in their NYHA functional class, septal thickness reduction, LVOT gradient reduction, and improvement of exercise capacity when compared with patients who did not require pacing. CONCLUSIONS Multiple demographic, electrocardiographic, and technical factors seem to increase the risk of CHB after NSRT. Patients with CHB after NSRT derive similar clinical and hemodynamic benefit to patients who did not require permanent pacing. (C) 2003 by the American College of Cardiology Foundation.
引用
收藏
页码:296 / 300
页数:5
相关论文
共 50 条
  • [1] CYANOACRYLATE FOR NONSURGICAL SEPTAL REDUCTION THERAPY IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
    Oto, A.
    Aytemir, K.
    Okutucu, S.
    Cil, B.
    Peynircioglu, B.
    Kaya, E. B.
    Deniz, A.
    Evranos, B.
    Sahiner, L.
    Kabakci, G.
    Tokgozoglu, L.
    Ozkutlu, H.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 147 : S70 - S71
  • [2] Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy
    Reinhard, W
    Ten Cate, FJ
    Scholten, M
    de Laat, LE
    Vos, J
    AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (08): : 1064 - 1066
  • [4] Induced septal infarction nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy
    Kuhn, HJ
    CIRCULATION, 1998, 97 (07) : 708 - 709
  • [5] Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients
    Lakkis, N
    Plana, JC
    Nagueh, S
    Killip, D
    Roberts, R
    Spencer, WH
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (05): : 583 - +
  • [6] Left ventricular septal hypoperfusion following nonsurgical septal reduction therapy in patients with obstructive hypertrophic cardiomyopathy.
    He, ZX
    Lakkis, NM
    Nagueh, S
    Mahmarian, JJ
    Kleiman, NS
    Spencer, WH
    Verani, MS
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 31P - 31P
  • [7] Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy - Outcome in the first series of patients
    Knight, C
    Kurbaan, AS
    Seggewiss, H
    Henein, M
    Gunning, M
    Harrington, D
    Fassbender, D
    Gleichmann, U
    Sigwart, U
    CIRCULATION, 1997, 95 (08) : 2075 - 2081
  • [8] Incidence and Clinical Impact of Complete Heart Block After Alcohol Septal Ablation Treatment of Hypertrophic Obstructive Cardiomyopathy.
    Terajima, Yutaka
    Konami, Yutaka
    Inoue, Masayuki
    Suzuyama, Hiroto
    Kodama, Kazuhisa
    Taguchi, Eiji
    Horibata, Yoko
    Nakao, Koichi
    Sakamoto, Tomohiro
    CIRCULATION, 2018, 138
  • [9] Left ventricular remodelling after nonsurgical septal reduction therapy for obstructive hypertrophic cardiomyopathy
    Nagueh, SF
    Spencer, WH
    Lakkis, NM
    Zoghbi, WA
    Kleiman, NS
    Killip, DM
    Roberts, R
    Quinones, MA
    CIRCULATION, 1997, 96 (08) : 3277 - 3277
  • [10] Induced septal infarction nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy - Response
    Sigwart, U
    CIRCULATION, 1998, 97 (07) : 709 - 709